Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 23Carcinoma, Transitional Cell 15Neoplasms 14Ovarian Neoplasms 13Carcinoma, Renal Cell 13Urinary Bladder Neoplasms 12Carcinoma, Merkel Cell 12Squamous Cell Carcinoma of Head and Neck 11Colorectal Neoplasms 8Triple Negative Breast Neoplasms 7Pancreatic Neoplasms 7Neoplasm Metastasis 7Melanoma 7Stomach Neoplasms 6Recurrence 5Breast Neoplasms 5Carcinoma, Hepatocellular 3Uterine Cervical Neoplasms 2Small Cell Lung Carcinoma 2Sarcoma 2Lymphoma, Non-Hodgkin 2Kidney Neoplasms 2Kidney Diseases 2Head and Neck Neoplasms 2Fallopian Tube Neoplasms 2Central Nervous System Neoplasms 2Carcinoma, Squamous Cell 2Carcinoma, Ovarian Epithelial 2Uveal Melanoma 1Urothelial Cancer 1

Interventions

trifluridine tipiracil drug combination 1rubitecan 1repotrectinib 1pevonedistat 1pembrolizumab 1ozanimod 1linifanib 1ledipasvir, sofosbuvir drug combination 1fisogatinib 1ficlatuzumab 1durvalumab 1avelumab 1atezolizumab 1Trabectedin 1Sorafenib 1Ramucirumab 1Irinotecan 1Immunotherapy 1Electroporation 1Dexamethasone 1Bevacizumab 1Azacitidine 1Axitinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Liver Diseases × avelumab × Clear all
NCT03289533 2020-09-04

A Study Of Avelumab In Combination With Axitinib In Advanced HCC (VEGF Liver 100)

Pfizer

Phase 1 Completed
22 enrolled 25 charts
Gastrointestinal

Carcinoma, Hepatocellular, Liver Diseases, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡